Provepharm Life Solutions develops pharmaceutical products based on known molecules, mainly for hospital use in France, the USA and the UK.
Founded in 1998 in Marseille, France, by Michel Feraud, Provepharm develops specialized medications for hospital settings and specialty care, marketed directly in France, the USA and the UK. Its customers are hospitals and specialty clinics. Michel Feraud continues as CEO. The company reported revenue of USD 15.27 mn and EBITDA of USD 8.36 mn in 2023. Its July 2021 funding is intended for new product launches and entry into additional countries.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in